Geographical variation in incidence of prostate cancer in Sweden - Survey from the National Prostate Cancer Register
(2005) In Scandinavian Journal of Urology and Nephrology 39(5). p.372-379- Abstract
- Objective. To investigate the geographical variation in prostate cancer incidence in Sweden, in particular the incidences of screening-detected tumours and curative treatment of prostate cancer. Material and methods. Data were retrieved from the National Prostate Cancer Register of Sweden for all cases of prostate cancer diagnosed in the year 2000-01. There were a total of 14 376 cases of prostate cancer and the mean total annual age-adjusted incidence was 197/100 000 men. There were 3318 cases in tumour category T1c, i.e. non-palpable tumours diagnosed during work-up for an elevated serum level of prostate-specific antigen, 1006 of which (30%) were asymptomatic and detected at a health checkup. Results. The difference between the counties... (More)
- Objective. To investigate the geographical variation in prostate cancer incidence in Sweden, in particular the incidences of screening-detected tumours and curative treatment of prostate cancer. Material and methods. Data were retrieved from the National Prostate Cancer Register of Sweden for all cases of prostate cancer diagnosed in the year 2000-01. There were a total of 14 376 cases of prostate cancer and the mean total annual age-adjusted incidence was 197/100 000 men. There were 3318 cases in tumour category T1c, i.e. non-palpable tumours diagnosed during work-up for an elevated serum level of prostate-specific antigen, 1006 of which (30%) were asymptomatic and detected at a health checkup. Results. The difference between the counties with the lowest and highest age-adjusted incidences per 100 000 men of total prostate cancer was almost twofold (128 vs 217). The corresponding variation in incidence of category T1c tumours was more than fourfold (13 vs 60); the difference in incidence of T1c tumours detected in asymptomatic men was up to 10-fold (2 vs 20); and there was more than a fourfold variation in incidence of curative treatment between counties (13 vs 67). Measured incidences were mostly highest in urban regions and in counties with university hospitals. Conclusion. There are large geographical variations in prostate cancer incidence and in the frequency of curative treatment for prostate cancer in Sweden and there appear to be large geographical variations in the uptake of prostate cancer screening. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/214409
- author
- organization
- publishing date
- 2005
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- register, incidence, prostate cancer, screening
- in
- Scandinavian Journal of Urology and Nephrology
- volume
- 39
- issue
- 5
- pages
- 372 - 379
- publisher
- Taylor & Francis
- external identifiers
-
- wos:000232883400004
- pmid:16257838
- scopus:27944448905
- ISSN
- 0036-5599
- DOI
- 10.1080/00365590500375463
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Clinic of Neurology: University Hospital, Lund (LUR000008), Department of Clinical Sciences, Lund (013230000)
- id
- b78af277-4193-48cb-afee-aae933e540d8 (old id 214409)
- date added to LUP
- 2016-04-01 17:14:35
- date last changed
- 2022-01-29 01:22:33
@article{b78af277-4193-48cb-afee-aae933e540d8, abstract = {{Objective. To investigate the geographical variation in prostate cancer incidence in Sweden, in particular the incidences of screening-detected tumours and curative treatment of prostate cancer. Material and methods. Data were retrieved from the National Prostate Cancer Register of Sweden for all cases of prostate cancer diagnosed in the year 2000-01. There were a total of 14 376 cases of prostate cancer and the mean total annual age-adjusted incidence was 197/100 000 men. There were 3318 cases in tumour category T1c, i.e. non-palpable tumours diagnosed during work-up for an elevated serum level of prostate-specific antigen, 1006 of which (30%) were asymptomatic and detected at a health checkup. Results. The difference between the counties with the lowest and highest age-adjusted incidences per 100 000 men of total prostate cancer was almost twofold (128 vs 217). The corresponding variation in incidence of category T1c tumours was more than fourfold (13 vs 60); the difference in incidence of T1c tumours detected in asymptomatic men was up to 10-fold (2 vs 20); and there was more than a fourfold variation in incidence of curative treatment between counties (13 vs 67). Measured incidences were mostly highest in urban regions and in counties with university hospitals. Conclusion. There are large geographical variations in prostate cancer incidence and in the frequency of curative treatment for prostate cancer in Sweden and there appear to be large geographical variations in the uptake of prostate cancer screening.}}, author = {{Stattin, P and Johansson, R and Lodnert, R and Andren, O and Bill-Axelsson, A and Bratt, Ola and Damber, JE and Hellstrom, M and Hugosson, J and Lundgren, R and Tornblom, M and Varenhorst, E and Johansson, JE}}, issn = {{0036-5599}}, keywords = {{register; incidence; prostate cancer; screening}}, language = {{eng}}, number = {{5}}, pages = {{372--379}}, publisher = {{Taylor & Francis}}, series = {{Scandinavian Journal of Urology and Nephrology}}, title = {{Geographical variation in incidence of prostate cancer in Sweden - Survey from the National Prostate Cancer Register}}, url = {{http://dx.doi.org/10.1080/00365590500375463}}, doi = {{10.1080/00365590500375463}}, volume = {{39}}, year = {{2005}}, }